My love for computers started with a trusty Compaq back in 2005, and I haven't looked back since. This had me graduate into being an avid tinkerer, even if I end up soft-bricking stuff most of the ...
Jupyter Notebook is a tool to run and write Python code easily, showing results right away, and allowing you to combine code, charts, notes, and files in one place. You can start Jupyter Notebook ...
Apple appears to have closed the loophole that let Mac users skip the Siri AI waitlist in the latest macOS 27 Golden Gate ...
Getting back from macOS 27 Golden Gate beta to macOS Tahoe 26 requires erasing your drive. There is no in-place downgrade, no undo option, and no shortcut around that fact. This guide covers the three ...
Spread the love“`html Whether you’re troubleshooting pesky issues, preparing to sell your device, or just want a clean slate, knowing how to reinstall macOS can be a game-changer. This guide offers a ...
Spread the love“`html Booting your Mac in recovery mode is a crucial skill for anyone who wants to troubleshoot issues, reinstall the operating system, or restore data. Whether you’re dealing with a ...
This week’s recap covers exploited flaws, supply chain attacks, phishing kits, AI lures, macOS stealers, urgent CVEs, tools, ...
Matt Elliott is a senior editor at CNET with a focus on laptops and streaming services. Matt has more than 20 years of experience testing and reviewing laptops. He has worked for CNET in New York and ...
At WWDC 2026, Apple announced the official name for the next macOS operating system: macOS 27 Golden Gate. The new operating system will be available this fall for MacBooks and Mac devices with M1 ...
A MacBook Air on display in an Apple store, with the lid raised and keyboard visible. - aapsky/Shutterstock Getting used to pressing the Command key instead of Control on a Mac may be one of the most ...
The SEC has conditionally approved Nasdaq PHLX to list cash-settled, European-style bitcoin index options under the ticker QBTC, which still await CFTC approval. QBTC options will be settled in U.S.
The FDA has approved a dosing update for burosumab-twza (Crysvita, Kyowa Kirin) to allow for increased dose and frequency when needed in adults with X-linked hypophosphatemia (XLH). In XLH, the ...